about
Expression of sterol regulatory element-binding transcription factor (SREBF) 2 and SREBF cleavage-activating protein (SCAP) in human atheroma and the association of their allelic variants with sudden cardiac deathScreening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individualsBruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domainStructural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase diseaseRecommendations for locus-specific databases and their curationGenome-wide selection of unique and valid oligonucleotides.Dynamic covariation between gene expression and proteome characteristicsCrystal structure of a 1.6-hexanediol bound tetrameric form of Escherichia coli lac-repressor refined to 2.1 A resolutionSolution structure of the SH3 domain from Bruton's tyrosine kinaseIsolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene familyThe autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding proteinIdentification of novel transcription factor-like gene from human intestinal cellsOverexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysisHuman Proteinpedia enables sharing of human protein dataCharacterization of CA XIII, a novel member of the carbonic anhydrase isozyme familyPON-P2: prediction method for fast and reliable identification of harmful variantsSharing data between LSDBs and central repositoriesStandard development at the Human Variome ProjectVariation Ontology for annotation of variation effects and mechanismsVarioML framework for comprehensive variation data representation and exchangePseudoGeneQuest - service for identification of different pseudogene types in the human genomeInteraction between Btk TH and SH3 domain.Intermolecular interactions between the SH3 domain and the proline-rich TH region of Bruton's tyrosine kinase.Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).Rational design and purification of human Bruton's tyrosine kinase SH3-SH2 protein for structure-function studies.Thermal unfolding of small proteins with SH3 domain folding pattern.BTKbase, mutation database for X-linked agammaglobulinemia (XLA)BTKbase, mutation database for X-linked agammaglobulinemia (XLA).Tec homology (TH) adjacent to the PH domain.Structural basis of ICF-causing mutations in the methyltransferase domain of DNMT3B.Probing the alpha-complementing domain of E. coli beta-galactosidase with use of an insertional pentapeptide mutagenesis strategy based on Mu in vitro DNA transposition.The structural basis of hyper IgM deficiency - CD40L mutations.Characterization of all possible single-nucleotide change caused amino acid substitutions in the kinase domain of Bruton tyrosine kinase.Immunity genes and their orthologs: a multi-species database.Establishment of an international database for genetic variants in esophageal cancer.Spectrum of disease-causing mutations in protein secondary structuresPhenCode: connecting ENCODE data with mutations and phenotype.Expanded national database collection and data coverage in the FINDbase worldwide database for clinically relevant genomic variation allele frequencies.A statistical score for assessing the quality of multiple sequence alignments.High-precision mapping of protein protein interfaces: an integrated genetic strategy combining en masse mutagenesis and DNA-level parallel analysis on a yeast two-hybrid platform.
P50
Q21245533-C379EF0B-2B9A-4ACE-BF9C-123F75BD8BEAQ22000758-8EF1B831-CF80-45CE-96F0-42916064383CQ24321955-E1E945A4-3847-49B9-9D2B-CE66870ECF2EQ24564000-E9106BEB-572E-484F-817A-5447EC2F1CB3Q24646762-3D80AC7E-072B-4F4B-981A-93C89404B42CQ24814825-00320AC6-40D1-4C66-AED9-A41E3A4B6194Q24816534-16F7708D-C610-41B4-90B2-925D9EB28F68Q27652876-622BF723-04C5-4CDC-933F-D2D952090680Q27748889-9CAD86E1-5E1D-4D2D-83D6-DC23E5A07D16Q28138517-CE61D784-408A-4756-B09F-B7BBEF9019DFQ28140689-C89122F2-52F4-407E-B1FF-80489C1F77E0Q28140819-3CE932EE-1C21-4088-B459-1F18EF029DC6Q28198226-1BAFBA2D-9249-4757-A5ED-CE7836666721Q28267923-CAF48122-677E-41CE-8742-E5713EEA0548Q28513669-D8BEED72-269E-4A91-A876-24BC736A700CQ28543185-2CA6A37A-35F8-4D0C-BD85-C1700892308BQ28648442-DEB5F4B3-C87F-4D30-AB8B-117BD2ED9527Q28651486-F06DDBBE-E5C9-4010-A405-1172FA9D025EQ28659580-80424A29-4AA8-402E-9C24-4A761FA8BA6CQ28710506-6EA3983C-F922-4E8F-A020-ED338083B6CEQ28757758-7757C500-1BA5-401F-878A-BEFCF39EE622Q30167540-84AD5FC9-D794-46AC-8CE0-BDEA9ACD59E6Q30168418-9838691C-7330-4B2A-9389-15FE4B8CB778Q30168594-0F64F971-261E-4D6D-9609-C3ECE19023F0Q30168608-D3C8A46D-CDDD-4911-B029-62EA085D97D8Q30176191-81112EC5-6350-4ABB-BA7C-B9320A138D44Q30176696-812E50EF-FD3C-4209-9709-CC162A24CF09Q30192775-30B518DE-33CD-41B7-8262-EDFF0360856DQ30194119-A0339768-030D-4B0A-9956-5A6C8B81E4DBQ30332535-B18FC720-C113-4466-B412-3A78A5F48678Q30339082-CBBDB2FE-1013-40C1-9D55-112B8B533DCCQ30359929-D9EF10BE-6842-48DC-8DBC-6E7806A6AEA3Q30372772-E01E57B2-FA92-4685-ACE1-A4D933EB1807Q30483592-D0590BBC-8BBF-4FDC-B147-E2F7F9EE9894Q30489600-7FF44DE2-E068-422B-9625-13690F3E0646Q30500895-1CA25CC0-884C-453E-BFFF-47E2849688B9Q31103056-E45CF501-5CF1-418C-B5B2-10B80753F32CQ31147213-0CA0D37F-84CE-4295-A7E6-C9AC55AC0FEBQ33262518-B3D4FD7D-53AF-464A-9C9C-8D91888B9B45Q33294327-3EEA30DE-C65E-4AD4-ADCC-AA1C8C5C02CD
P50
description
Fins onderzoeker
@nl
hulumtues
@sq
researcher
@en
հետազոտող
@hy
name
Mauno Vihinen
@ast
Mauno Vihinen
@en
Mauno Vihinen
@es
Mauno Vihinen
@nl
Mauno Vihinen
@sl
type
label
Mauno Vihinen
@ast
Mauno Vihinen
@en
Mauno Vihinen
@es
Mauno Vihinen
@nl
Mauno Vihinen
@sl
prefLabel
Mauno Vihinen
@ast
Mauno Vihinen
@en
Mauno Vihinen
@es
Mauno Vihinen
@nl
Mauno Vihinen
@sl
P106
P1153
7005414036
P21
P2456
P27
P31
P496
0000-0002-9614-7976
P569
2000-01-01T00:00:00Z